Member Info for JOHNO77

Yes CM - It’s a shame that a one time multi trick pony has become a one trick currently limping pony.... Maybe destined for the glue factory? Will soon find out.

Nice looking buy there. Holding for an uodate before the week is out. Be good to see some decent numbers and new targets to excite the market.

Blimey, thank god I thought I was talking to myself! Hi JFK. I like the look of this one. Tiny mCap plus it’s still nice and quiet here, the best time to get in IMO. GLA

Haha he's not messing around with those lumps is he??

Cmon Nige we said good results not inconsistent ones... ;)

Yo. Am still here. Letting the SP quietly go about it’s business.

This is making a nice change, onwards and upwards for N4P.

Hopefully not bad news tho Nige.....

My av is 3.9 so i'm more than happy. I think the downside from here is limited so IMO the only way is up.

A few buys on Friday, maybe the bottom is in??

Next few Wks or so should be very interesting.

This week????????????????

New website is great, much better than the old one. Aren't we due a technology update this wk?

Once the roll out becomes nationwide I can see this flying.

Hi MV, Well best of luck, I think the next couple of Q’s will have plenty in store. Looks like plenty going on behind the scenes, particularly manufacturing, to get us deal ready. Agree re web site but it’s a big improvement. Who knows re Charty, banned for life???? Cheers, Johno

Agreed, the new site looks much more polished Baggy and it seems they are putting the placing proceeds to good use in other areas too.

Am hoping the Adelaide results are as impressive.

These low levels not got you interested then mv??

Anytime now hopefully WB

Yep personally happy to wait. Am just hoping that the near term news from UofA is positive.

I would assume that the recently increased PR is to engage better with the investment community more than commercial partners. I personally wouldn't use that as a gauge of the progress of any commercial discussions.

Anyone buying previously at 5/6p levels has been handsomely rewarded and I don’t see this time being any different... If Nuvec progresses as we all hope then this could be the last chance to get em cheap...

Ps. Re’ reading rns’es I wasn’t talking about you there Vander

AZN is clearly not dead is it. People need to read the last rns properly. Also suits n4 not to get in too deep with medimmune at this stage otherwise it could hinder the business model of ‘multiple collaboration parteners’. Med would have too much leverage over N4 if they chucked money at us now. Better to do it as we are using our own money. Good results from UofA studies would make a big statement. The rest of this year is all about putting the infrastructure in place for deals. Lots of catalysts for SP growth still to come in the coming months IMO.